417 related articles for article (PubMed ID: 27405845)
1. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
Gatto M; Ghirardello A; Luisetto R; Bassi N; Fedrigo M; Valente M; Valentino S; Del Prete D; Punzi L; Doria A
J Autoimmun; 2016 Nov; 74():208-216. PubMed ID: 27405845
[TBL] [Abstract][Full Text] [Related]
2. Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings.
Gatto M; Radu CM; Luisetto R; Ghirardello A; Bonsembiante F; Trez D; Valentino S; Bottazzi B; Simioni P; Cavicchioli L; Doria A
J Autoimmun; 2020 Jul; 111():102443. PubMed ID: 32265078
[TBL] [Abstract][Full Text] [Related]
3. PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis.
Bassi N; Del Prete D; Ghirardello A; Gatto M; Ceol M; Zen M; Bettio S; Mantovani A; Iaccarino L; Punzi L; Doria A
Clin Rev Allergy Immunol; 2015 Oct; 49(2):217-26. PubMed ID: 25805362
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant.
Bassi N; Luisetto R; Ghirardello A; Gatto M; Bottazzi B; Shoenfeld Y; Punzi L; Doria A
Reumatismo; 2012 Dec; 64(6):380-7. PubMed ID: 23285482
[TBL] [Abstract][Full Text] [Related]
5. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
Yuan M; Tan Y; Pang Y; Li YZ; Song Y; Yu F; Zhao MH
Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
9. 17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice.
Bassi N; Luisetto R; Ghirardello A; Gatto M; Valente M; Della Barbera M; Nalotto L; Punzi L; Doria A
Lupus; 2015 Apr; 24(4-5):382-91. PubMed ID: 25801881
[TBL] [Abstract][Full Text] [Related]
10. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
[TBL] [Abstract][Full Text] [Related]
11. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
[TBL] [Abstract][Full Text] [Related]
12. Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in naïve mice.
Ben-Ami Shor D; Blank M; Reuter S; Matthias T; Beiglass I; Volkov A; Barshack I; Shoenfeld Y
J Autoimmun; 2014 Nov; 54():118-26. PubMed ID: 24662148
[TBL] [Abstract][Full Text] [Related]
13. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.
Gilkeson GS; Ruiz P; Pippen AM; Alexander AL; Lefkowith JB; Pisetsky DS
J Exp Med; 1996 Apr; 183(4):1389-97. PubMed ID: 8666897
[TBL] [Abstract][Full Text] [Related]
14. C1q regulatory region polymorphism down-regulating murine c1q protein levels with linkage to lupus nephritis.
Miura-Shimura Y; Nakamura K; Ohtsuji M; Tomita H; Jiang Y; Abe M; Zhang D; Hamano Y; Tsuda H; Hashimoto H; Nishimura H; Taki S; Shirai T; Hirose S
J Immunol; 2002 Aug; 169(3):1334-9. PubMed ID: 12133956
[TBL] [Abstract][Full Text] [Related]
15. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus.
Bassi N; Ghirardello A; Blank M; Zampieri S; Sarzi-Puttini P; Mantovani A; Shoenfeld Y; Doria A
Ann Rheum Dis; 2010 Sep; 69(9):1704-10. PubMed ID: 20439287
[TBL] [Abstract][Full Text] [Related]
16. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
[TBL] [Abstract][Full Text] [Related]
17. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.
Fismen S; Mortensen ES; Rekvig OP
Immunol Cell Biol; 2011 Jan; 89(1):90-9. PubMed ID: 20548325
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
Radanova M; Vasilev V; Deliyska B; Kishore U; Ikonomov V; Ivanova D
Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
[TBL] [Abstract][Full Text] [Related]
20. Comparison of natural antibodies to autoantibodies arising during lupus in (NZB x NZW)F1 mice.
Hentati B; Ternynck T; Avrameas S; Payelle-Brogard B
J Autoimmun; 1991 Apr; 4(2):341-56. PubMed ID: 1883482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]